Grande Group Limited

Sources: FY2026 20-F (FY2024–FY2026 income statement; FY2025–FY2026 balance sheet); FY2025 20-F and IPO F-1 (FY2023 rounded figures); aggregator data (TipRanks, ROIC.ai, AlphaQuery, Benzinga) where noted. FY2021–FY2022 not publicly disclosed. FY2023 figures are rounded/aggregator-derived and carry lower precision.

Income statement: notes and sources

Notes: FY2023 revenue (≈US$3.9M per filings; US$3.87M per aggregator), gross profit (≈US$2.3M), pre-tax income (≈US$1.5M) and net income (≈US$1.3M) are rounded filing figures; FY2023 operating income is derived from an aggregator operating margin of 38.39%. EBITDA is left blank because depreciation and amortization were not separately captured; the business is asset-light and D&A is immaterial, so operating income is a close proxy (FY2026 EBITDA excluding impairment ≈ −US$1.37M). Some aggregators report FY2026 net loss attributable to shareholders of ≈US$3.47M, implying ≈US$0.07M of loss allocated to non-controlling interests (Wicens minority); the 20-F consolidated net loss is US$3,537,209. The FY2025 DPS of ≈US$0.03 reflects the HK$6M pre-IPO subsidiary dividend paid to the controlling shareholder, divided by shares outstanding; no dividend has ever been paid to public shareholders. Weighted share counts are retroactively adjusted; FY2023–FY2024 per-share figures from ROIC.ai.

Margins and growth (%)

Revenue CAGR: FY2023–FY2026 three-year CAGR ≈ −12.7%; FY2024–FY2026 two-year CAGR ≈ −24.6%.

Half-year detail

Commentary: H1 FY2026 revenue fell 83.2% and gross profit turned negative (cost of revenue exceeded revenue). H2 FY2026 benefited from the related-party referral fee and Proplus course-material revenue but absorbed the goodwill impairment. The H1 unrealized loss on an equity security (US$0.37M) was crystallized as a US$0.41M realized loss on disposal for the full year — evidence that part of the IPO cash was deployed into a listed equity position that lost value. The security's identity was not captured.

Balance sheet: notes and sources

Notes: FY2023–FY2024 balance-sheet figures from aggregators (TipRanks/VCP Scanner). The FY2023 "total debt" of US$1.86M reported by aggregators appears to reflect amounts due to related parties/other liabilities rather than bank borrowings; no bank debt has been identified in any filing. FY2026 tangible equity deducts goodwill only; any acquired intangibles within other non-current assets (≈US$2.8M of non-current assets beyond goodwill and right-of-use assets, composition not captured) would reduce it further. The composition of the ≈US$2.2M increase in current liabilities (possible deferred acquisition consideration, accrued one-time bonuses, payables) was not captured; this is a key diligence item.

Cash flow: notes and sources

Sources: FY2025 OCF US$794.15K (FY2025 20-F); FY2026 OCF/ICF/FCF (Benzinga/AlphaQuery, consistent with 20-F cash movement of −US$614.6K); FY2023–FY2025 ICF/FCF (TipRanks). FY2025 "capex" equals investing outflow as reported by aggregator and may include non-capex items. The FY2026 investing outflow of US$10.35M is dominated by the HK$78M Proplus consideration (US$0.55M paid in H1, likely as a deposit). The FY2026 financing inflow of US$10.47M comprises the US$9.78M net IPO proceeds plus ≈US$0.7M of other inflows, plausibly minority capital in China CreateAlliance (not confirmed).

Ratios

ROIC is not presented: with negative-to-tiny invested capital in FY2023–FY2024, aggregator ROIC figures (292% FY2024, 79% FY2025) are mathematically valid but analytically meaningless, and FY2026 ROIC is deeply negative. Net debt/EBITDA and interest coverage are not meaningful (no borrowings, no interest expense, negative FY2026 EBITDA). A cash conversion cycle is not applicable for a fee-based advisory firm; receivable days were not captured.

Financial commentary — trends, inflections, drivers

1. FY2023–FY2024: the profitable-boutique phase. Three IPO completions per year drove revenue from ≈US$3.9M to US$4.5M with gross margins of 60–67% and net margins near 40%. Cash generation was solid (FY2024 OCF ≈US$1.16M) and equity turned positive from a deficit, aided by retained profits.

2. FY2025: hidden deterioration. Headline revenue fell only 4.2%, but IPO sponsorship revenue collapsed 92% (zero completions). The gap was filled by doubled advisory revenue and a new US$1.6M referral stream. G&A rose 60% (pre-IPO costs) and a HK$6M dividend was paid to the controlling shareholder ahead of the IPO.

3. FY2026: inflection to losses. Revenue fell 40.6%; G&A more than doubled to US$2.97M (one-time discretionary bonuses, client-acquisition travel and entertainment, U.S. listing maintenance costs, consolidation of acquired entities). A US$1.94M goodwill impairment was booked within six months of closing the Proplus deal because the reporting unit's carrying amount exceeded its fair value. A US$0.41M loss on equity securities added to the drag. Net loss: US$3.54M.

4. Balance-sheet transformation. IPO cash (US$9.78M net) was almost entirely converted into goodwill. At March 31, 2026, goodwill was 55% of assets, cash had fallen to US$1.45M (below the FY2023 level), working capital was −US$2.2M and tangible equity was ≈US$0.03M. The auditor added a substantial-doubt going-concern paragraph citing the working capital deficit, accumulated deficit, net loss and operating cash outflow.

5. Liquidity bridge. The July 2026 White Lion equity line (up to US$40M over 36 months) is the principal disclosed funding source; its drawdown capacity depends on share price and trading volume.

Management guidance

None. The company has issued no revenue, margin or profitability guidance; it states only an expectation that Wicens will contribute revenue in subsequent periods.

Consensus growth expectations

None available (no sell-side coverage).

Bull case (grounded in data)

1. Cyclical leverage to a booming HK market: HKEX raised ≈HK$286B across ≈119 IPOs in 2025 with a 400+ company queue into 2026; a single completed sponsorship plus coupled underwriting via Wicens could restore revenue toward the US$4.5M FY2024 level, where the model earned ≈40% net margins.

2. Platform now complete: For the first time the group owns sponsor (Type 6), unrestricted dealer/underwriter (Wicens Type 1) and a Mainland founder-education funnel (Shenzhen Zhenjing), enabling capture of sponsor, underwriting, placing, brokerage and compliance-annuity economics per client.

3. Funded runway: The US$40M ELOC dwarfs the FY2026 operating cash burn (US$0.73M) and could finance FRR liquid-capital needs and growth if the share price holds above ≈US$0.80.

Bear case (grounded in data)

1. Core franchise erosion: No IPO completions since FY2024, IPO revenue down 97% from FY2024 to FY2026, and only 2 Mainland clients in FY2026 — despite record HK market conditions — suggest a structural, not cyclical, loss of competitiveness.

2. Capital allocation and quality-of-earnings concerns: Effectively all net IPO proceeds (US$9.78M) were spent on a business with ≈US$0.96M run-rate revenue, ≈21% of whose goodwill was impaired within six months; 29.9% of FY2026 revenue came from a related party; tangible equity is ≈US$0.03M.

3. Going concern and dilution spiral: Negative working capital (−US$2.2M), auditor substantial doubt, and an ELOC priced at discounts to the lowest trading prices create a reflexive dilution risk; at US$1.30, full usage implies ≈55% dilution of all existing holders, and below US$0.80 the facility cannot deliver the full commitment without further registration.

Key catalysts and monitorables (next 12 months)

Analyst verdict

Grande Group is no longer the business it was when it filed to go public. Through FY2024 it was a small but genuinely profitable Hong Kong sponsor boutique: three IPO completions a year, US$4.5M of revenue, 40% net margins and no debt. Since then, the sponsorship engine has stalled — zero completions in FY2025 and only US$105K of IPO revenue in FY2026 — even as Hong Kong became the world's busiest IPO venue.

Management's response has been to redeploy capital rather than rebuild origination. The US$10M Proplus purchase consumed essentially all net IPO proceeds for a Shenzhen course-materials business formed months earlier, and the subsequent US$1.94M impairment within half a year undermines confidence in acquisition discipline. Thematic announcements in Web3 and AI infrastructure have yet to produce disclosed revenue. Meanwhile, FY2026 revenue fell 41%, G&A more than tripled versus FY2024, the company swung to a US$3.5M loss, working capital turned negative, and the auditor flagged substantial doubt about the company's ability to continue as a going concern. A related party supplied almost 30% of revenue, and the CFO seat has turned over twice.

The White Lion equity line removes near-term solvency risk but converts it into dilution risk, priced off the lowest trades in a thin, volatile stock. At ≈US$29M market capitalization the shares trade at ≈11x sales and roughly 4x book — with book almost entirely goodwill — leaving little margin of safety.

Upside exists if Wicens and Grande Capital can convert Hong Kong's deep IPO pipeline into coupled sponsor-underwriter mandates; proof would be new A1 filings and Wicens revenue in the H1 FY2027 report. Until such evidence appears, the risk–reward is unfavourable: a speculative, governance-sensitive turnaround best monitored rather than owned.